TSM:NYSETaiwan Semiconductor Manufacturing Company Ltd. Analysis
Data as of 2026-08-18 - not real-time
$413.41
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At $413.41, Taiwan Semiconductor Manufacturing Company Limited shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it lost 4.4%. RSI sits at 47.3, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $372.72 up to resistance at $436.04.
The shares look fair, trading on 31.2 times earnings below a sector average of 35.7. Sell-side targets cluster 32.3% above the current quote. Revenue is growing at 36.0% on a 49.9% profit margin.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 39.1%, a beta of 2.19 and a maximum drawdown of 21.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.
The shares look fair, trading on 31.2 times earnings below a sector average of 35.7. Sell-side targets cluster 32.3% above the current quote. Revenue is growing at 36.0% on a 49.9% profit margin.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 39.1%, a beta of 2.19 and a maximum drawdown of 21.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.
Top Market Events
Magellan Investment Partners, an Australian investment management company, released its second-quarter 2026 investor...Second quarter net profit rose 77% year-over-year to a record T$706.Giverny Capital Asset Management, LLC, an investment management company, recently published its second-quarter 2026...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 364.68
- MACD momentum is positive
- Beta of 2.19 versus the benchmark
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 31.2 versus sector average of 35.7
- Trading above the 200-day average of 364.68
- Analyst targets imply +32.3% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 31.2 versus sector average of 35.7
- Analyst targets imply +32.3% versus the current price
- Profit margin of 49.9% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth36.00%
Profit Margin49.92%
P/E Ratio31.2
ROE39.97%
ROA19.00%
Debt/Equity16.50
P/B Ratio86.2
Op. Cash Flow$2634.7B
Free Cash Flow$730.8B
Industry P/E35.7
Technical Analysis
TrendNeutral
RSI47.3
Support$372.72
Resistance$436.04
MA 20$413.01
MA 50$424.85
MA 200$364.68
MACDBullish
VolumeDecreasing
Fear & Greed Index93.14
Valuation
Fair Value$5,371.15
Target Price$547.09
Upside/Downside32.34%
GradeFair
TypeGrowth
Risk Assessment
Beta2.19
Volatility39.13%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.